Form 4: Ultragenyx EVP Karah Parschauer Sells 9,806 Shares of Common Stock

Karah Parschauer, EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc., sold 9,806 shares of common stock at $45 per share on June 12, 2024.

Summary

• On June 12, 2024, Karah Parschauer, the EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc., sold 9,806 shares of common stock.
• The sale price was $45 per share.
• Following the transaction, Parschauer directly owns 57,981 shares of Ultragenyx common stock.
• This total includes 447 shares acquired under the company's Amended and Restated Employee Stock Purchase Plan on April 30, 2024.
• It also includes previously reported shares of common stock underlying RSUs granted to Parschauer, which are subject to certain vesting conditions.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't inherently indicate positive or negative sentiment about the company's future.

Industry Context

Insider sales are a common occurrence and are often scrutinized by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, they can also be part of a pre-planned diversification strategy.

Stakeholder Impact

• The sale of shares by a high-ranking executive could be perceived negatively by some shareholders, potentially leading to concerns about the company's future prospects.
• However, the impact is likely to be minimal given the relatively small number of shares sold compared to the total outstanding shares.

Key Dates